- Home
- BQ vs INM Comparison
BQ vs INM Comparison
Compare BQ & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BQ
- INM
- Stock Information
- Founded
- BQ 2008
- INM 1981
- Country
- BQ China
- INM Canada
- Employees
- BQ N/A
- INM N/A
- Industry
- BQ Other Specialty Stores
- INM Biotechnology: Pharmaceutical Preparations
- Sector
- BQ Consumer Discretionary
- INM Health Care
- Exchange
- BQ Nasdaq
- INM Nasdaq
- Market Cap
- BQ 2.5M
- INM 2.3M
- IPO Year
- BQ 2020
- INM N/A
- Fundamental
- Price
- BQ $2.12
- INM $2.08
- Analyst Decision
- BQ
- INM
- Analyst Count
- BQ 0
- INM 0
- Target Price
- BQ N/A
- INM N/A
- AVG Volume (30 Days)
- BQ 11.9K
- INM 15.0K
- Earning Date
- BQ 04-08-2025
- INM 05-13-2025
- Dividend Yield
- BQ N/A
- INM N/A
- EPS Growth
- BQ N/A
- INM N/A
- EPS
- BQ N/A
- INM N/A
- Revenue
- BQ $81,208,354.00
- INM $4,832,013.00
- Revenue This Year
- BQ N/A
- INM N/A
- Revenue Next Year
- BQ N/A
- INM N/A
- P/E Ratio
- BQ N/A
- INM N/A
- Revenue Growth
- BQ N/A
- INM N/A
- 52 Week Low
- BQ $2.01
- INM $1.99
- 52 Week High
- BQ $7.40
- INM $15.70
- Technical
- Relative Strength Index (RSI)
- BQ 33.54
- INM 26.67
- Support Level
- BQ $2.01
- INM $1.99
- Resistance Level
- BQ $2.62
- INM $2.66
- Average True Range (ATR)
- BQ 0.14
- INM 0.15
- MACD
- BQ 0.00
- INM -0.05
- Stochastic Oscillator
- BQ 16.18
- INM 9.34
About BQ Boqii Holding Limited representing
Boqii Holding Ltd operates in the business of selling pet products through online stores. The store provides pet foods, health products, pet grooming products, pet bathing products, pet toys, fish tank, aquatic fertilizer, temperature control equipment, oxygen pump and other related products. Also, the company sells its products through offline channels to pet stores and hospitals.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.